Jeffrey L. Radke, Co-Founder and CEO of Accelerant Holdings (NYSE:ARX), sold 80,000 Class A Common Shares on July 6, 2026, for approximately $1.1 million, as disclosed in a recent SEC Form 4 filing.
Transaction summary
Key questions
What is the significance of this sale relative to the CEO’s total position?The sale of 80,000 shares represents a roughly 0.3% reduction of Jeffrey L. Radke total equity holdings, which remain substantial at 28.6 million shares following the transaction.
What was the mechanism and timing of the transaction?This disposition was executed according to a Rule 10b5-1 trading plan adopted on March 24, 2026, which allows insiders to schedule stock sales in advance to meet liquidity needs while adhering to regulatory requirements.
How are the remaining shares distributed across different entities?Radke maintains 333,652 shares in direct ownership, while approximately 28.3 million shares are held indirectly through Badly Bent LLC and a trust for the benefit of his spouse.
How do the company’s fundamentals compare to the transaction size?The $1.1 million sale is small relative to the company’s $2.9 billion market capitalization and its reported trailing-twelve-month revenue of $887.1 million as of the July 6, 2026 market close.
Company Overview
Company Snapshot
Accelerant Holdings operates a data-driven risk exchange platform that facilitates connections between specialty insurance underwriters and risk capital partners, generating revenue through exchange services, MGA operations, and underwriting segments.
The company’s business model leverages proprietary technology, data ingestion capabilities, and agency operations to create a marketplace that enables efficient capital deployment and risk distribution across the specialty insurance ecosystem.
The company serves specialty insurance underwriters and institutional risk capital partners seeking exposure to specialty insurance risks through a transparent, technology-enabled exchange platform.
Accelerant Holdings operates as a specialized financial services platform within the property and casualty insurance sector. The company’s competitive positioning centers on its proprietary data-driven exchange infrastructure that streamlines the connection between underwriting capacity and risk capital, addressing structural inefficiencies in the specialty insurance market. Accelerant functions as a critical intermediary in the specialty insurance value chain, enabling more efficient capital allocation and risk transfer mechanisms.
What this transaction means for investors
This sale ultimately looks like a founder taking a small portion of his stake off the table for what could be a plethora of reasons. Radke set the trading plan in March, and 80,000 shares is a rounding error against the roughly 28.6 million he still controls, the bulk of it held indirectly through an LLC. When a co-founder CEO parts with about three-tenths of a percent of his position under a preset schedule, the only real signal is that he has expenses like anyone else.
The business is scaling well for a company that’s been public for less than a year, even if the underlying stock has been struggling. First-quarter operating revenue jumped to $273.2 million from $174 million, exchange written premium topped $1 billion for a fourth straight quarter, and adjusted EBITDA climbed 70% to $66.1 million as Accelerant leaned into its capital-light, fee-based model. CFO Linda Huber pointed to fee-based revenue and EBITDA rising 52% and 112%, and management guided to at least $5.2 billion in exchange premium for the year. Shares took a steep hit early in their run amid partner concentration concerns and net losses, which totaled $4.1 million for the quarter compared to net income of $7.8 million, so ultimately, long-term investors should stay focused as management looks to turn the firm into “the rails on which specialty insurance run.”
Should you buy stock in Accelerant right now?
Before you buy stock in Accelerant, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Accelerant wasn’t one of them. The 10 stocks that made the cut are built for long-term growth and could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $395,679!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,294,805!*
That performance is why people listen. With a track record of beating the S&P 500 by 4x, Stock Advisor offers a distinct advantage. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built for the long haul.
See the 10 stocks »
*Stock Advisor returns as of July 12, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
What This $1.1 Million Insider Sale at Accelerant Means for Investors was originally published by The Motley Fool
